Dan Hargrove is the co-founder and president of Cancer Insight, LLC, a clinical research organization dedicated to discovering, developing and testing emerging biotechnologies related to cancer immunotherapy. His expertise spans biotechnology commercialization, FDA regulatory compliance, government contracts, and military law.